METEORIC-HF
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects with Heart Failure with Reduced Ejection Fraction and Decreased Exercise Tolerance
- Stage
- klaar
- Medicine
- Omecamtiv Mecarbil
- Population
- Hartfalen
- Phase
- III
- First Patient In
- 9 July 2020
- Last Patient In
- 8 June 2021
- Last Patient Last Visit
- 30 November 2021
National Lead
prof. dr. A. Voors
Cardioloog
Office Contact
